Citigroup Inc Halozyme Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 112,717 shares of HALO stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,717

Previous 68,316 64.99%

Holding current value

$5.36 Million

Previous $3.58 Million 80.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$51.3 - $64.42 $2.28 Million - $2.86 Million	44,401 Added 64.99%	112,717 $6.45 Million
Q2 2024 Aug 12, 2024	SELL	$37.81 - $52.4 $5.72 Million - $7.93 Million	-151,304 Reduced 68.89%	68,316 $3.58 Million
Q1 2024 May 10, 2024	BUY	$33.68 - $41.95 $2.35 Million - $2.93 Million	69,729 Added 46.52%	219,620 $8.93 Million
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $1.46 Million - $1.85 Million	43,966 Added 41.51%	149,891 $5.54 Million
Q3 2023 Nov 09, 2023	SELL	$36.46 - $44.03 $821,152 - $991,643	-22,522 Reduced 17.53%	105,925 $4.05 Million
Q2 2023 Aug 10, 2023	SELL	$30.28 - $38.74 $1.32 Million - $1.69 Million	-43,659 Reduced 25.37%	128,447 $4.63 Million
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $2.89 Million - $4.89 Million	87,867 Added 104.31%	172,106 $6.57 Million
Q4 2022 Feb 09, 2023	SELL	$40.06 - $59.44 $5.27 Million - $7.81 Million	-131,470 Reduced 60.95%	84,239 $4.79 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $4.23 Million - $5.69 Million	109,825 Added 103.72%	215,709 $8.53 Million
Q2 2022 Aug 10, 2022	BUY	$37.35 - $48.3 $2.44 Million - $3.16 Million	65,432 Added 161.75%	105,884 $4.66 Million
Q1 2022 May 12, 2022	SELL	$31.97 - $41.06 $4.07 Million - $5.23 Million	-127,346 Reduced 75.89%	40,452 $1.61 Million
Q4 2021 Feb 10, 2022	BUY	$31.82 - $40.75 $2.04 Million - $2.61 Million	64,073 Added 61.77%	167,798 $6.75 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $3.99 Million - $4.81 Million	103,725 New	103,725 $4.22 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account